financetom
Business
financetom
/
Business
/
Millicom Board Committee Says Atlas Luxco's Raised Offer Undervalues Shares
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Millicom Board Committee Says Atlas Luxco's Raised Offer Undervalues Shares
Aug 9, 2024 7:08 AM

09:33 AM EDT, 08/09/2024 (MT Newswires) -- Millicom International Cellular ( TIGO ) board's independent committee said Friday that the increased offer of Atlas Luxco still "significantly" undervalues the company and reiterated its recommendation that the shareholders reject the offer and not tender their shares.

The committee said it considered Millicom's "strong" Q2 financial results and sought an updated opinion from Nordea in its review of the revised offer price.

Atlas Luxco, a unit of Atlas Investissement, increased its offer to buy Millicom shares on Aug. 2 to $25.75 per share after the Millicom board committee rejected the July 1 initial offer of $24 per share, Millicom said.

Atlas Luxco is the largest shareholder of Millicom through its affiliates, holding about 29% of the share capital and the total number of votes in Millicom as of Aug. 2, according to the board committee.

Price: 25.54, Change: -0.05, Percent Change: -0.20

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Mar 12, 2024
01:46 PM EDT, 03/12/2024 (MT Newswires) -- Consumer stocks were higher Tuesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) increasing 0.5% and the Consumer Discretionary Select Sector SPDR Fund (XLY) rising 0.9%. Redbook US same-store sales rose by 3% from a year earlier in the week ended March 9 after a 3.1% year-over-year increase in the previous...
Ultragenyx Pharmaceutical Insider Sold Shares Worth $574,644, According to a Recent SEC Filing
Ultragenyx Pharmaceutical Insider Sold Shares Worth $574,644, According to a Recent SEC Filing
Mar 12, 2024
01:45 PM EDT, 03/12/2024 (MT Newswires) -- Thomas Richard Kassberg, Chief Business Officer & Executive Vice President, on March 11, 2024, sold 11,509 shares in Ultragenyx Pharmaceutical ( RARE ) for $574,644. Following the Form 4 filing with the SEC, Kassberg has control over a total of 252,823 shares of the company, with 252,823 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1515673/000095017024029780/xslF345X03/ownership.xml...
Fox, DISH Network Strike Distribution Deal for Fox Nation
Fox, DISH Network Strike Distribution Deal for Fox Nation
Mar 12, 2024
01:53 PM EDT, 03/12/2024 (MT Newswires) -- Fox's (FOX) Fox Nation direct-to-consumer subscription streaming service expanded its distribution to Dish Network's (DISH) Dish TV and Sling TV, Fox Nation said Tuesday. Financial details weren't disclosed. Beginning mid-March, Dish subscribers can add Fox Nation for $5.99 per month, while the service will also be available for the same price to all...
Top Midday Gainers
Top Midday Gainers
Mar 12, 2024
01:56 PM EDT, 03/12/2024 (MT Newswires) -- Regulus Therapeutics ( RGLS ) said Tuesday that the second cohort of patients in a phase 1b study of RGLS8429 for Autosomal Dominant Polycystic Kidney Disease showed clear evidence of a mechanistic dose-response over placebo. Shares surged past 86% in recent trading as intraday trading volume soared to over 146 million from a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved